Bio-Gene Cash from 2010 to 2025

Stocks . Australia . 
Stock . Bio Gene Technology
BGT Stock   0.03  0  10.00%   
Bio-Gene Technology Cash yearly trend continues to be comparatively stable with very little volatility. Cash is likely to outpace its year average in 2025. Cash is the total amount of money in the form of currency that Bio Gene Technology has in its possession. This includes all bills, coins, and funds in bank accounts. View All Fundamentals
 
Cash  
First Reported
2017-06-30
Previous Quarter
1.7 M
Current Value
2.2 M
Quarterly Volatility
2 M
 
Covid
Check Bio-Gene Technology financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bio-Gene Technology's main balance sheet or income statement drivers, such as Depreciation And Amortization of 39.4 K, Interest Expense of 63.8 K or Selling General Administrative of 1.7 M, as well as many indicators such as . Bio-Gene financial statements analysis is a perfect complement when working with Bio-Gene Technology Valuation or Volatility modules.
  
This module can also supplement various Bio-Gene Technology Technical models . Check out the analysis of Bio-Gene Technology Correlation against competitors.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Bio-Gene Stock Analysis

When running Bio-Gene Technology's price analysis, check to measure Bio-Gene Technology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio-Gene Technology is operating at the current time. Most of Bio-Gene Technology's value examination focuses on studying past and present price action to predict the probability of Bio-Gene Technology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio-Gene Technology's price. Additionally, you may evaluate how the addition of Bio-Gene Technology to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY